Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States
Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. Patients outside clinical trials seldom benefit from evidence‐based monitoring. The objective of this study was to estimate the cost‐effectiveness of complying with HCC screening guidelines. The economic evaluat...
Saved in:
| Published in: | Hepatology (Baltimore, Md.) Vol. 65; no. 4; pp. 1237 - 1248 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Wolters Kluwer Health, Inc
01.04.2017
|
| Subjects: | |
| ISSN: | 0270-9139, 1527-3350, 1527-3350 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!